Hopstem
Dr. Valina Dawson has received funding support of more than 60 million US dollars from NIH and other foundations, and has published more than 221 top academic articles, with an H index of 123, and total citations of 63,689.
This person is not in the org chart
This person is not in any offices
Hopstem
Hopstem is a pharmaceutical company engaged in human iPSCs/ESCs neural differentiation, cell banking, and cell engineering.